Andersons pediatric cardiology 1595

1984;54:153–159.
323.LamWC,PennellDH.Imagingoftheheart:
historicalperspectiveandrecentadvances.
PostgradMedJ.2016;92:99–104.
324.Candell-RieraJ,LuL,SeresL,etal.Cardiac
hemochromatosis:beneficialeffectsofiron
removaltherapy.Anechocardiographicstudy.
AmJCardiol.1983;52(7):824–829.
325.GoldmuntzEA,WhitePH.Juvenileidiopathic
arthritis:areviewforthepediatrician.Pediatr
Rev.2006;27(4):e24–e32.
326.GoldenbergJ,FerrazMB,PessoaAP,etal.
Symptomaticcardiacinvolvementinjuvenile
rheumatoidarthritis.IntJCardiol.
1992;34(1):57–62.
327.CoulsonEJ,NgWF,GoffI,etal.Cardiovascular
riskinjuvenileidopathicarthritis.Rheum.
2013;52:1163–1171.
328.SilverRM.Clinicalaspectsofsystemicsclerosis.
AnnRheumDis.1991;50(suppl4):854–861.
329.StojanovichL,MilovanovichB,deLukaSR,et
al.Cardiovascularautonomicdysfunctionin
systemiclupus,rheumatoidarthritis,primary
sjogrensyndromeandotherautoimmune
diseases.Lupus.2007;16(3):181–185.
330.DentonCP,NihtyanovaSI.Therapyof
pulmonaryarterialhypertensioninsystemic


sclerosis:anupdate.CurrRheumatolRep.
2007;9(2):158–164.

331.D'AngeloWA,FriesJF,MasiAT,etal.
Pathologicobservationsinsystemicsclerosis
(scleroderma):studyoffifty-eightautopsies
casesandfifty-eightmatchedcontrols.AmJ
Med.1969;46:428–440.
332.AktozM,YilmaztepeM,TatliE,etal.
Assessmentofventricularandleftatrial
mechanicalfunctions,atrialelectromechanical
delayandPwavedispersioninpatientswith
scleroderma.CardiolJ.2011;18:261–269.
333.vanLaarJM,StolkJ,TyndallA.Scleroderma
lung:pathogenesis,evaluationandcurrent
therapy.Drugs.2007;67(7):985–996.
334.JohnstonSL,LockRJ,GompelsMM.Takayasu
arteritis:areview.JClinPathol.
2002;55(7):481–486.
335.HiratzkaLF,BakrisGL,BeckmanJA,etal.2010
ACCF/AHA/AATS/ASA/SCA/SCAI/SIR/STS/SVM
guidelinesforthediagnosisandmanagementof
patientswiththoracicaorticdisease.Circulation.
2010;121:e266–e369.
336.RuigeJB,VanGeetC,NevelsteenA,Verhaeghe
R.A16-yearsurveyofTakayasu'sarteritisina
tertiarybelgiancenter.IntAngiol.
2003;22(4):414–420.


337.MiyamaeT,ImagawaT,KatakuraS,etal.[A
caseofclassicalpolyarteritisnodosadiagnosed
bymyocardialbiopsy].NihonRinshoMeneki

GakkaiKaishi.2002;25(2):184–190.
338.GunalN,KaraN,CakarN,etal.Cardiac
involvementinchildhoodpolyarteritisnodosa.
IntJCardiol.1997;60(3):257–262.
339.KingKK,KornreichHK,BernsteinBH,Singsen
BH,HansonV.Theclinicalspectrumof
systemiclupuserythematosusinchildhood.
ArthritisRheum.1977;20(2):287–294.
340.AnsariA,LarsonPH,BatesHD.Cardiovascular
manifestationsofsystemiclupuserythematosus:
currentperspective.ProgCardiovascDis.
1985;27:421–434.
341.TanEM,CohenAS,FriesJF,etal.The1982
revisedcriteriafortheclassificationofsystemic
lupuserythematosus.ArthritisRheum.
1982;25:1217–1277.
342.HochbergMC.UpdatingtheAmericancollege
ofrheumatologyrevisedcriteriaforthe
classificationofsystemiclupuserythematosis.
ArthritisRheum.1997;40(9):1725.
343.ChungJW,JoeDY,ParkHJ,etal.Clinical
characteristicsoflupusmyocarditisinkorea.
RheumatolInt.2007.
344.LaneAT,WatsonRM.Neonatallupus